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Abstract
Objective—Fluctuations in ovarian hormones during the menstrual cycle and psychosocial stress
contribute to eating disorder (ED) behavior.
Methods—Using ecological momentary assessment techniques, this study examined
relationships between stress and binge eating, self-induced vomiting, and dietary restriction based
on menstrual cycle status in anorexia nervosa (AN). 109 females with full and subthreshold AN
(17–45 years old) recorded ED behavior and stress ratings over two weeks. Using hierarchical
linear modeling, individuals with eumenorrhea and those with amenorrhea or oligomenorrhea
were compared.
Results—Following episodes of meal skipping, momentary stress decreased in individuals with
normal menstrual cycles and increased in those with irregular menstrual cycles.
Discussion—Results suggest that changes in stress severity in response to food restriction may
differ based on ovarian hormonal status and may be a mechanism by which AN is maintained in
individuals without menstrual disturbance.
Anorexia nervosa (AN) is a severe psychiatric illness associated with high rates of morbidity
and mortality1,2. Characterized by an intense drive for thinness and desire to lose weight,
individuals with AN fear fatness, experience body image distortion and exaggerate the
importance of body shape and size in self-evaluation. Biological factors are thought to
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influence AN symptomatology; however, mechanisms underlying development and
maintenance of the disorder remain incompletely understood3.
Several lines of research have investigated reproductive hormonal function in the context of
eating disorder (ED) psychopathology. In a longitudinal study of female twins, Klump, Burt,
McGue, and Iacono4 examined changes in genetic and environmental influence on
disordered eating (DE) throughout adolescence. While environmental contributions
remained stable or decreased over time, variance in DE accounted for by genetic factors
increased between early (6%) and late adolescence (45%). Changes during pubertal
development are thought to account for differing heritability estimates5. More specifically,
estradiol, an ovarian hormone (measured via saliva) that increases during puberty, has been
shown to moderate genetic influence on DE, such that correlations between measures of DE
are greater in monozygotic twins than dizygotic twins who have higher concentrations of
estradiol compared to those with lower concentrations of the hormone6. It is possible that
rising levels of ovarian hormones during adolescence increase the risk for ED development
in individuals with a genetic vulnerability.
In addition to etiological influences, research in rodent and human populations has indicated
that ovarian hormones are associated with normal and aberrant patterns of eating behavior.
For instance, increased food intake in ovariectomized rats has been shown to reverse with
administration of exogenous estrogen7, where progesterone seems to attenuate estradiol’s
anorexigenic effect, increasing food intake8. Studies in non-clinical populations have shown
that food craving and intake are associated with hormonal changes across the normal
menstrual cycle. Women have reported higher levels of craving and consumption in late
luteal menstrual phases, when progesterone and estrogen are high but decreasing, compared
to the follicular phase when estrogen is elevated9. Prospective studies of ovarian hormones
in community samples and in individuals diagnosed with bulimia nervosa who report
current, regular menses have shown that decreasing levels of estradiol and increasing levels
of progesterone are linked to higher rates of clinically significant binge eating10,11 whereas
interactions between estrogen and progesterone during the mid-luteal phase are associated
with increases in emotional eating12, or eating in response to negative emotions, not
physiological hunger cues.
Research has yet to examine ovarian hormone function and ED pathology in AN. AN-like
symptomatology is seen across a wide spectrum of menstrual cycle regularity, where
individuals with AN symptoms report menstruation frequency ranging from absent or
infrequent to more regular and consistent13. Although the DSM-IV-TR required amenorrhea
(cessation of three or more consecutive menstrual cycles14), it has been removed from the
DSM-5 on account of evidence that suggests amenorrhea reflects nutritional status, not
differences in core psychological or behavioral symptoms15,16. Individuals with amenorrhea
or oligomenorrhea (present but irregularly or infrequently occurring menstrual cycles; A/O)
possess decreased mean levels of ovarian hormones compared to eumenorrhic (EU), or
normal menstruating, females17. Comparing EU to A/O can, therefore be a proxy for
studying differences between normal versus aberrant ovarian hormonal function. Doing so
in AN could improve our understanding of endocrine factors that contribute to maintenance
of ED behavior in this population.
Stress has also been widely studied in EDs and has been shown to be associated with AN
symptomatology. For instance, severe life stress, assessed retrospectively, differs between
AN and control samples, predating AN onset in 67% of cases18. In epidemiological samples,
chronic stress has been frequently reported within the year prior to ED onset19, and
individuals with acute AN have reported higher levels of total life stress and more difficulty
coping with stress than controls20.
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Reactivity of the stress system appears to fluctuate with changes in ovarian hormones. In
animal studies, administration of estrogen alpha and beta receptor agonists have been shown
to increase and decrease stress-related behavior respectively21. In healthy women,
physiological responses to physical and psychological stressors, indicated by increased heart
rate, noradrenaline and cortisol secretion has been shown to increase during the luteal phase
of the menstrual cycle22,23. Similarly, an fMRI study examining the effects of stress on
neural responsivity to emotional stimuli concluded that stress sensitivity, measured by
amygdala and medial prefrontal cortex activity following exposure to a psychological
stressor, was greater during the luteal phase of the cycle compared to the follicular phase24.
Action of ovarian hormones in brain regions that modulate activity of the hypothalamic-
pituitary-adrenal axis are thought to contribute to observed changes in stress sensitivity
across the menstrual cycle25. Although evidence suggests that ovarian hormones and stress
affect ED behavior, little is known about the relationship between these variables and how
they influence momentary food restriction, binge eating, and self-induced vomiting in AN.
One means of teasing apart the temporal order of these variables is with a methodology
known as ecological momentary assessment (EMA).
EMA has received increasing attention in ED research26–28 and offers many advantages
over other types of assessments conducted in circumscribed laboratory visits. It measures
variables in real-world environments that are more ecologically valid29. EMA reduces
retrospective recall bias and memory errors inherent in standard self-report. It also facilitates
repeated assessment that, with computerized technology, can date and time-stamp
recordings, allowing for investigation of temporal relationships30.
Research has yet to examine how differences in menstrual cycle regularity, an indirect
measure of ovarian hormone function, interacts with changes in stress to affect eating in
individuals with AN. To begin to explore this question, this study is the first to examine the
momentary relationship between stress and ED behavior in AN as a function of menstrual
cycle status using EMA. We hypothesized that ratings of stress would increase prior to and
decrease following discrete episodes of meal skipping, binge eating, and self-induced
vomiting in individuals with both A/O and EU but that the rate of change in stress ratings
would be greater in those reporting normal menstrual cycle function.
METHODS
Participants
Data from 109 females, 17–45 years old, were analyzed from part of a larger 3-site study. A
total of 121 participants met full eligibility criteria, agreed to participate and were enrolled.
Of those enrolled as part of the larger study, three participants with EMA compliance rates
less than 50% and nine who endorsed use of hormonal contraceptives were excluded from
analyses in the present study. Additionally, participants had to meet DSM-IV-TR criteria for
restricting or binge-purge type AN or subclinical AN. Subclinical AN was defined as
meeting criteria for full AN with any single one of the following exceptions: 1) BMI
between 17.5 and 18.5, or, 2) absence of amenorrhea, or 3) denial of fearing fatness or body
image disturbance. Individuals without fear of fatness or body image disturbance but who
were significantly low weight and endorsed amenorrhea were included in this study based
on research suggesting that these individuals are highly similar to those with full threshold
AN in regards to eating disorder symptoms and general personality and psychopathology
variables31–33. Adopting more lenient AN inclusion criteria allowed us to examine
differences in stress and eating disorder variables based on menstrual cycle status among a
more inclusive spectrum of AN pathology. Non-English speakers and those who endorsed
psychosis, substance dependence, gastrointestinal surgery or who were medically unstable,
pregnant, breastfeeding, or had been hospitalized within six weeks prior to study onset were
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excluded. The study did not enroll individuals recently initiating psychotherapy or
pharmacotherapy; however, those on stable treatment regimens (at least 6 weeks) who
continued to show a consistent pattern of ED behavior were included. Participants were
divided into groups based on self-reported menstrual cycle frequency assessed during the
Eating Disorder Examination34. An EU group (n=47) was comprised of individuals
reporting 5 to 7 menstrual cycles over the previous 6 months (equivalent to 26–36 day
cycles). The A/O group (n=62) consisted of individuals reporting 4 or fewer cycles over the
same time period. Participants were asked to report how many total menstrual cycles they
had over the previous six months; however, information regarding which months
menstruation occurred was not provided. This prevented the separation between amenorrhea
and oligomenorrhea; therefore, the two were combined for analysis.
Assessments
Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition
(SCID-I/P35)—This study employed the SCID-I/P, a semi-structured clinical interview used
to assess AN and other current and lifetime DSM-IV-TR Axis 1 disorders.
Eating Disorder Examination (EDE34)—The EDE is a clinician-administered interview
that served as the primary measure of ED pathology. This instrument assesses restraint,
eating concerns, shape concerns and weight concerns as well as frequency of ED behavior.
Both the SCID-I/P and EDE have well documented reliability and validity34–36 and are
commonly used in psychiatric research. Twenty-five percent of interviews were randomly
selected and rated by an independent assessor. Kappa coefficients for current AN diagnoses
on the SCID-I/P (n=30) were .929. Intraclass correlation coefficients for the EDE scales
(n=31) ranged from .894 (Shape Concerns) to .997 (Restraint).
EMA Measures
Daily Stress—Twenty-three self-report items assessed daily stress. Fifteen were drawn
from the Daily Stress Inventory37 to measure interpersonal stressors (e.g., argued with
family). This questionnaire has shown convergent validity with endocrine stress measures38.
Eight additional items measured body image (e.g., saw body), eating (e.g., eating high risk
food), and ED treatment-related stressors (e.g., saw therapist). These situations were
selected to assess potentially stressful situations specific to patients with AN. Items were
included to reflect clinical and empirical significance in this population while reducing the
overall burden of assessment. Participants reported which stressful events occurred and how
stressful each event was on a 5-point scale (1=not at all, 5=very much), yielding a stress
severity score.
ED Behaviors—Participants were asked to report all eating episodes and to specify
whether they ate an unusually large amount of food (that which “would be considered an
excessive quantity by most people”) and/or felt a loss of control (“an inability to stop
eating”) or drive to eat (“an inability to prevent the episode”)3,4. Frequency of objective
bulimic episodes (OBE; eating a large amount of food accompanied by a sense of loss of
control) and subjective bulimic episodes (SBE; eating a small/modest quantity of food
associated with a sense of loss of control) for each participant was obtained with this
measure. Participants also recorded self-induced vomiting and meal skipping episodes
(MSEs).
Procedures
Participants were recruited at the three sites from ED treatment facilities, provider mailings,
and flyers throughout the community. Institutional review board approval was obtained at
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each site. Interested participants underwent an initial phone screening to assess basic
inclusion criteria. Those eligible were scheduled for a visit where they signed informed
consent. Enrolled participants completed two subsequent visits consisting of 1) a physical
examination with a research physician to ensure medical stability, and 2) diagnostic
interviews administered by trained research staff. The EMA assessment schedule used in
this study has been described previously27. To maximize data quality and optimize the
strengths of different recording methods, this study combined the use of interval, random,
and event-contingent recordings. Participants were instructed to complete EMA ratings
following six semi-random daily beeps delivered to a Palm Pilot computer between 8:30a.m.
and 9:50p.m. (random recordings). They also completed ratings at the end of each day
(interval recording) and whenever they engaged in target behaviors (event-contingent
recording). If individuals felt unable to reply (e.g., during class) or if responding posed a
safety risk (e.g., while driving), individuals were instructed to delay responding until the
environment permitted. Participants received extensive training in how to define behaviors
of interest and operate Palm Pilot equipment. They were asked to carry the device for two
practice days before meeting with research staff to receive feedback. Practice data were
excluded from analysis. Participants were then asked to carry the Palm Pilot and complete
recordings for 2 weeks. They were compensated $100 per week and given a $50 bonus for
complying with at least 80% of all recordings.
Statistics
Results were analyzed using SPSS (Version 19.0). Demographic data, behavioral frequency,
and EDE subscale scores were examined using independent sample t-tests, Pearson chi-
square tests, and analysis of variance (ANOVA) respectively. A mixed-effects, hierarchical
linear model (days nested within participant) was employed to test differences in stress
ratings between groups on days when ED events occurred compared to non-ED behavior
days. Momentary analyses were conducted using hierarchical linear modeling described
previously27.
RESULTS
EMA Assessments
Compliance rates to random signals averaged 86% (range = 58–100%) and 87% (range =
69–99%) for the A/O and EU groups respectfully; 77% (range = 31–99%) of all signals were
responded to within 45 minutes. End-of-day rating compliance averaged 90% for the A/O
group (range = 28–100%) and 89% for individuals with EU (range = 24–100%).
Demographic, Behavioral and Clinical Data
See Table 1 for demographic and clinical variables. Groups did not differ in age or ethnic
background. 69.4% of the A/O group met diagnostic criteria for the restricting subtype,
compared to 53.7% of the EU group. Similarly, individuals with A/O were more likely to
meet diagnostic criteria for full AN (χ2(1, N=109)=9.23, p<0.05), by definition. As
expected, there was a trend towards higher average BMI in the EU group compared to the A/
O group. To account for this trend, BMI was added as a covariate in subsequent analyses.
To examine differences in ED pathology, EDE subscales and behavioral frequencies were
compared. There were no differences in rates of MSEs, vomiting, or SBEs between A/O or
EU. The EU group reported a higher percentage of days with OBE episodes compared to the
A/O group. Groups did not differ in their degree of Dietary Restraint, Eating Concern,
Weight Concern, or Shape Concern as assessed by the EDE. Similar rates of comorbid
anxiety and mood disorders were observed for both groups. It is important to note that there
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were no differences in variables of interest (i.e., ED behavior frequency, stress ratings)
between those meeting full versus subthreshold AN.
EMA Between and Within Day (Momentary) Results
Similar to methods used in previous EMA studies27, repeated stress ratings within days were
combined to produce a daily measure of overall stress severity. When aggregated over the 2-
week study period, individuals with A/O reported higher total stress severity (M=18.89,
SE=1.46) compared to individuals with EU (M=14.27, SE=1.67, F(1, 106)=4.27, p<.05).
Trends suggest that this difference may be due to the A/O group reporting a greater number
of stressors (M=7.70, SE=0.52) over the two weeks (EU: M=6.29, SE=0.60, F(1, 106)=3.09,
p=.08) which were rated as more stressful on average (M=6.34, SE=0.29) compared to those
with EU (M=2.81, SE=0.34, F(1, 106)=3.38, p=.07). For the entire sample, stress severity
scores on days when OBEs (M=19.20, SE=1.41), SBEs (M=21.78, SE=1.82), and self-
induced vomiting (M=19.55, SE=1.35) occurred were greater compared to symptom-free
days (OBE M=16.21, SE=1.10; SBE M=16.46, SE=1.10; Vomiting M=15.90, SE=1.11, all
p’s<0.01). This pattern was not observed for meal skipping.
There were no differences in stress ratings between groups on days when binge eating or
vomiting occurred; however, there was a significant interaction between menstrual cycle
status and meal skipping (F(1,1488)=4.309, p<.05). The A/O group reported increased stress
severity when MSEs occurred (M=19.68, SE=1.58) compared to non-MSE days (M=18.52,
SE = 1.47). The opposite pattern was observed in the EU group (MSE days M=12.93,
SE=1.82; non-MSE days M=15.02, SE = 1.69).
Hierarchical linear modeling was used to examine changes in stress severity ratings
preceding and following binge eating, vomiting, and MSEs. Because ED behavior itself can
affect subsequent levels of subjective stress, only the first reported behavioral episode of
each day was included in the model in order to avoid using ratings confounded by previous
events, an approach employed previously27. Main effects and interactions included in the
multilevel model are presented in Table 2. Stress severity prior to MSEs did not differ;
however, stress following meal skipping appeared to differentiate A/O from EU.
Specifically, following MSEs, stress decreased in individuals with EU but increased in those
with A/O (F(1,1243)=4.12, p<.05). No differences were observed in momentary stress
ratings surrounding binge eating and vomiting between the two groups. Momentary results
are presented in Figure 1.
DISCUSSION
Previous research suggests that ovarian hormones and exposure to stressors contribute to ED
symptomatology. EMA provides a novel approach for investigating how these variables are
related. To our knowledge, this is the first study to specifically examine momentary
relationships between stress and ED behavior in AN based on menstrual cycle status. The
main finding of this study is that trajectories of self-reported stress differ between
individuals with A/O and EU following discrete meal skipping episodes. Results suggest
that in AN, normal menstrual cycles are associated with changes in stress severity
surrounding distinct episodes of dietary restriction and that restrictive behavior has a
fundamental relationship to such stress (i.e., reduces stress). Conversely, those with aberrant
menstrual function have persistently higher levels of stress that are less affected by the same
behavior. Trends suggest that the A/O group was more likely to meet criteria for the
restrictive AN subtype and to have a lower BMI. However, because meal skipping
frequency and EDE scores did not differ between the groups and because BMI was covaried
statistically, it is unlikely that the findings reflect any underlying differences in illness
severity.
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These results suggest that dietary restriction in AN may be maintained differently based on
hormonal status, where individuals with eumenorrhea are more sensitive to negative
reinforcing effects of stress reduction following restriction. With chronically lower levels of
estrogen and progesterone, restriction may be reinforced by other mechanisms in individuals
with A/O or, if learned early in the illness, it may be slow to extinguish even after
reinforcing effects are no longer present. Low levels of estradiol have been previously
shown to impair extinction learning in healthy adult women39 and in women diagnosed with
posttraumatic stress disorder40, so it is possible that continued restriction in A/O in the
absence of reinforcing effects may be due, in part, to decreased secretion of ovarian
hormones. As hormonal levels increase and normalize with weight gain during recovery, it
is possible that negative reinforcing effects re-emerge and further strengthen the pairing of
stress reduction and restrictive eating behaviors. This is consistent with both animal41 and
human studies42 that suggest behavioral conditioning and learning is facilitated by higher
estrogen concentrations through widespread effects on neural functioning in the brain43.
This pattern may partially contribute to the intractability of symptoms frequently observed
in AN, especially in the context of weight restoration. Additional research that more directly
examines within person changes in estrogen and progesterone in AN is needed to clarify the
mechanism by which ovarian hormones influence conditioning and extinction learning in
this population.
Irrespective of menstrual cycle status, between day analyses indicated that greater stress was
reported on days with binge eating or self-induced vomiting, which is consistent with
previous findings in BN27. In addition, patterns of daily stress associated with meal skipping
differentiated A/O and EU. Greater stress accompanied days when meal skipping occurred
in individuals with A/O whereas reductions in daily stress were associated with meal
skipping in participants with EU.
Several limitations are important to note. First, menstrual cycle status was determined via
retrospective self-report, not direct hormonal assay (e.g., saliva, blood samples). Similarly,
because this study did not assess prospective changes in hormonal concentrations, current
menstrual phase in those with EU was not accounted for. Ovarian hormones differ
throughout each phase of the menstrual cycle, and thus this should be addressed and
controlled for in future research. In addition, the assessment procedures prevented the
separation of individuals with current/past amenorrhea from those with oligomenorrhea.
Ovarian hormone function undoubtedly differs between these two conditions, and future
research using more precise biological measures should clarify how the relationship between
stress and dietary restriction differs as a result. Stress severity was similarly measured by
self-report and only examined within eight hours of a MSE. Stress experienced outside of
this time period likely affects the frequency of restrictive behavior at later time points.
Future studies should expand upon these findings, examining patterns of stress and AN
behavior over longer time periods. Lastly, these results should be replicated using more
direct biological measures of stress reactivity and ovarian hormones (e.g. salivary estradiol
and cortisol) and used to examine how within person changes in circulating estrogen and
progesterone concentrations and momentary changes in stress directly influence ED
behavior in AN.
Overall, findings from this study suggest that momentary changes in stress following
discrete episodes of food restriction in AN differ based on self-reported menstrual cycle
status. Individuals with normal ovarian hormonal function may be more sensitive to
behavior-induced reductions in subjective stress. If true, this suggests that optimal
treatments for AN may be personalized based on individual hormonal function. For
example, brief modifications of estrogen through pharmacological interventions could
potentially reduce the likelihood that negative reinforcement will maintain restrictive eating
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in individuals who present with normal menses (e.g., early during the illness as individuals
are losing weight or after menses have resumed following weight restoration). Additional
research is needed to replicate these findings, further investigating how hormonal factors
directly affect maintenance of AN symptoms. Such research has the potential to clarify the
viability of ovarian hormones as potential treatment targets for AN during certain phases of
the illness.
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Figure 1.
Momentary stress severity ratings captured within 4 hours before and after meal skipping
(time=0). Trajectories were significant (p<.05) post meal skipping.
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Table 1
Demographic and Clinical Variables.
Eumenorrhea (n=47) Amenorrhea/Oligomenorrhea (n=62)
Demographics Mean (SD) Mean (SD) t-statistic p-value
Age 23.91 (6.26) 24.81 (7.50) 0.66 .51
BMIa 17.36 (0.97) 17.00 (1.09) −1.80 .07
Ethnicity % of Participants (n) % of Participants (n) χ2 p-value
Caucasian 93.60 (44) 98.40 (61) 2.74 .25
African American 2.10 (1) 1.60 (1)
Other 4.30 (2) 0.00 (0)
AN Subtype Diagnosis
Full ANb 31.91 (15) 61.29 (38) 9.23 .00
Subthreshold AN 68.08 (32) 38.70 (24)
Restricting Subtype 53.20 (25) 69.40 (43) 2.98 .08
Binge/Purge Subtype 46.80 (22) 30.60 (19)
Comorbidity
Mood Disorder 21.30 (10) 24.20 (15) 0.13 .72
Anxiety Disorder 38.30 (18) 45.20 (28) 0.52 .47
Clinical Variables Mean(SD) Mean(SD) F statistic p-value
EDEc
Eating Concern 1.95 (1.54) 2.24 (1.20) 1.39 .24
Weight Concern 2.89 (1.67) 3.10 (1.58) 1.11 .29
Shape Concern 2.93 (1.74) 3.08 (1.46) 0.96 .32
Dietary Restraint 2.63 (1.73) 2.74 (1.48) 0.46 .49
ED Behavior Frequency % of Daysf % of Days X2 statistic p-value
Meal Skipping 32.00 31.60 0.03 .86
OBEd 13.30 9.10 7.45 .01
SBEe 3.90 2.80 1.57 .21
Self-induced Vomiting 19.40 18.40 0.25 .61
abody mass index.
bparticipants that met full DSM-IV-TR criteria for AN compared to those with subthreshold AN.
c
Eating Disorder Examination.
d
objective bulimic episode.
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e
subjective bulimic episode.
fpercent of days when at least one ED behavior was reported.
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Table 2
Multilevel results for within day stress severity ratings before and after the first reported meal skipping
episode (MSE) of the day.
Variable Estimate Standard Error T-statistic
Intercept 5.06 0.46 10.96**
Time prior to MSE −0.01 0.31 −0.02
Time prior to MSE2 −0.02 0.07 −0.33
Time prior to MSE3 0.00 0.00 −0.48
Time prior to MSE* First MSE 0.48 0.46 1.05
Time prior to MSE2* First MSE −0.05 0.08 −0.64
Time prior to MSE3* First MSE 0.00 0.00 1.07
Group 0.03 0.71 0.04
Time prior to MSE* Group 0.59 0.48 1.22
Time prior to MSE2* Group 0.12 0.10 1.12
Time prior to MSE3* Group 0.00 0.00 1.00
Time prior to MSE* First MSE* Group −1.52 0.71 −2.12*
Time prior to MSE3* First MSE* Group −0.01 0.00 −1.66
Note: The intercept reflects stress severity ratings at the time that the first MSE of the day was reported. Time prior to meal skipping, time prior to
meal skipping2, and time prior to meal skipping3 reflect the linear change in stress severity leading up to reported MSE, the acceleration in the
slope of stress severity ratings, and changes in the direction of the slope, respectively. Interactions between time and MSE reflect trajectories of
stress severity ratings following meal skipping episodes. Three-way interactions (time x First MSE x group) represent differences in the trajectories
of stress severity ratings following meal skipping episodes between the two groups.
*
p<0.05.
**
p<0.01.
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